2nd Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
—
Expenses
$463,244
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
JASON R MONEY —

Contacted: State, Dept of (DOS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); SENATE; Office of Management & Budget (OMB); Patent & Trademark Office (PTO); White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Congressional Budget Office (CBO)

Copyright/Patent/Trademark CPT

Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs S.515, S.610 and H.R.1260 - the Patent Reform Act of 2009, all provisions S.369 - Preserve Access to Affordable Generics Act, all provisions H.R.1706 - Protecting Consumers Access to Generic Drugs Act of 2009, all provisions H.R.3590 - Patient Protection and Affordable Care Act, Title VII Subtitle A - Biologics Price Competition and Innovation H.R.3962 - Affordable Health Care for America Act, Title V Subtitle C Part 2 - Biosimilars; Subtitle C Part 1 Section 2573 - Protecting Consumer Access to Generic Drugs H.R.4899 - War Supplemental Bill, Preseving Access to Affordable Generic Drugs Provision H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
JASON R MONEY —

Contacted: White House Office; Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Office of Management & Budget (OMB); State, Dept of (DOS)

Bills named: S. 515 (111th), H.R. 3962 (111th), H.R. 1706 (111th), H.R. 1260 (111th), H.R. 4899 (111th), S. 369 (111th), H.R. 3590 (111th), H.R. 4213 (111th), S. 610 (111th)

Medicare/Medicaid MMM

Health Care Reform, Budget Reconciliation, Implementation of Health Care Reform, Medicaid Reimbursement, Medicaid Rebates, The Deficit Reduction Act of 2006, prescription drug reimbursement, 340B Drug Pricing Program, Average Manufacture Price (AMP)/AMP Publication, Expanding rebates to Part D program, generic drugs H.R.3962 - Affordable Health Care for America Act - Title I, Subtitle E - Improvements to Medicare Part D; Title V Subtitle A - Drug Discount for Rural and Other Hospitals; 340B Program Integrity; Title VII Subtitle E - Financing; H.R.3590 - Patient Protection and Affordable Care Act; Title II Subtitle F - Medicaid Prescription Drug Coverage; Title VII Subtitle B - More Affordable Medicines for Children and Underserved Communities H.R.4213 - American Jobs and Closing Tax Loopholes Act of 2010 H.R.4899 - The War Supplemental Bill

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
JASON R MONEY —

Contacted: Congressional Budget Office (CBO); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Patent & Trademark Office (PTO); White House Office; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4213 (111th), H.R. 3590 (111th), H.R. 3962 (111th), H.R. 4899 (111th)

Budget/Appropriations BUD

Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY2011 Presidential Budget Request, FY2011 Congressional Budget and Appropriations H.R.2997 and S.1406 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 - Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
JASON R MONEY —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); White House Office; Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 1406 (111th), H.R. 2997 (111th)

Pharmacy PHA

Generic Biologics, Health Care Reform, Budget Reconcilliation, Implementation of Health Care Reform Bill, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies; Section 10609 Generic Drug Labeling H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole" H.R.4213 - American Jobs and Closing Tax Loopholes Act H.R.4899 - War Supplemental Bill

LobbyistCovered position, as disclosed
BILL HEAD —
KATHLEEN D JAEGER —
JASON R MONEY —

Contacted: HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Congressional Budget Office (CBO); Federal Trade Commission (FTC); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); U.S. Trade Representative (USTR)

Bills named: S. 726 (111th), H.R. 4213 (111th), H.R. 573 (111th), S. 882 (111th), H.R. 1548 (111th), H.R. 4899 (111th), S. 1232 (111th), H.R. 1427 (111th), H.R. 4872 (111th), H.R. 759 (111th), H.R. 3962 (111th), S. 501 (111th), H.R. 3590 (111th), H.R. 1298 (111th), S. 525 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.